Genome-Wide Determination of DNA Methylation by Hpa II Tiny Fragment Enrichment by Ligation-Mediated PCR (HELP) for the Study of Acute Leukemias
- 22 February 2009
- book chapter
- Published by Springer Nature
- Vol. 538, 395-407
- https://doi.org/10.1007/978-1-59745-418-6_20
Abstract
Aberrant distribution of cytosine methylation in cancer has been linked to deregulation of gene expression and genomic instability. DNA methylation changes in cancer include both hyper and hypomethylation, and the precise localization of these changes is directly related to the impact they have on gene regulation. To determine both the localization and extent of DNA methylation status under different conditions, we have developed the HpaII tiny fragment enrichment by ligation-mediated PCR (HELP) assay, a microarray-based technique that allows the simultaneous interrogation of the methylation status of hundreds of thousands of CpG dinucleotides. The HELP assay allows methylation levels throughout the genome to be accurately determined so that the epigenetic state of leukemia cells can be identified, compared, and contrasted.Keywords
This publication has 18 references indexed in Scilit:
- CG dinucleotide clustering is a species-specific property of the genomeNucleic Acids Research, 2007
- Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in miceBlood, 2007
- HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemiaCarcinogenesis: Integrative Cancer Research, 2007
- DNA Methylation of Tumor Suppressor Genes in Clinical Remission Predicts the Relapse Risk in Acute Myeloid LeukemiaCancer Research, 2007
- The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemiaBlood, 2007
- Comparative isoschizomer profiling of cytosine methylation: The HELP assayGenome Research, 2006
- Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoterBritish Journal of Haematology, 2006
- Gene Silencing in Cancer in Association with Promoter HypermethylationNew England Journal of Medicine, 2003
- Aberrant methylation and impaired expression of the p15INK4b cell cycle regulatory gene in chronic myelomonocytic leukemia (CMML)Leukemia, 2003
- Cancer epigenomicsHuman Molecular Genetics, 2002